Respiratory syncytial virus (RSV) is an important cause of viral lower respiratory tract illness
in infants and children globally, but no vaccine is currently available to protect these …

Although RSV has been a high priority for vaccine development, efforts to develop a safe
and effective vaccine have yet to lead to a licensed product. Clinical and epidemiologic …

Although respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract
infections in infants, a safe and effective vaccine is not yet available. Live-attenuated …

Respiratory syncytial virus (RSV), is a common cause of serious acute lower respiratory tract
illness in infants and young children, causing substantial morbidity and mortality globally …

RSV bronchiolitis is the leading cause of infant hospitalization in industrialized countries.
There is an unmet need to prevent RSV lower respiratory tract infection in young infants …

Human respiratory syncytial virus (RSV) is the leading cause of severe lower respiratory
tract infection, such as bronchiolitis, bronchitis, or pneumonia, in both infants and the elderly …

Human (HRSV) and bovine (BRSV) respiratory syncytial viruses (RSV) are two closely
related viruses, which are the most important causative agents of respiratory tract infections …

Respiratory syncytial virus (RSV) is the most important cause of lower respiratory tract
infections causing bronchiolitis and some mortality in young children and the elderly …

Highlights•Immunological goals for vaccination depend on whether it is for primary induction
or boosting of pre-existing immunity.•Boosting neutralizing activity is the major goal for …

Respiratory syncytial virus (RSV) infection is a major cause of severe respiratory disease in
infants and young children worldwide and also forms a serious threat for the elderly …